Legend Biotech (LEGN) net assets (shareholders' equity)

Net assets · fiscal 2025
$1.00B

Legend Biotech (LEGN) had net assets of $1.00B at the end of fiscal 2025 (December 31, 2025). That is 3.7% lower than the $1.04B of fiscal 2024. Figures as of 19 Nov 2026, 03:57 UTC, from Yahoo Finance.

Key facts

Net assets, fiscal 2025
$1.00B
Change on fiscal 2024
−3.7%
Highest on record
$1.25Bfiscal 2023
Lowest on record
$744.31Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Legend Biotech net assets (shareholders' equity), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $1.25B in fiscal 2023 and the lowest $744.31M in fiscal 2022.

History · 4 fiscal years

Net assets by fiscal year

Legend Biotech net assets (shareholders' equity), year by year

Legend Biotech (LEGN) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$1.00B 3.7% down
2024$1.04B 16.8% down
2023$1.25B 68.1% up
2022$744.31M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Legend Biotech and comparable companies
CompanyNet assetsFiscal year
Heartflow HTFL$300.65M2025
CRISPR Therapeutics CRSP$1.92B2025
Travere Therapeutics TVTX$114.83M2025
Option Care Health OPCH$1.33B2025
Legend Biotech LEGN$1.00B2025
Definium Therapeutics DFTX$332.33M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on LEGN

Legend Biotech, figure by figure

Legend Biotech (LEGN) overview: price, valuation and scorecardAll health care companies by market value

Legend Biotech net assets (shareholders' equity): questions and answers

What are Legend Biotech's net assets?

Legend Biotech (LEGN) had net assets of $1.00B at the end of fiscal 2025 (December 31, 2025). That is 3.7% lower than the $1.04B of fiscal 2024.

What are the highest and lowest net assets figures on record for Legend Biotech?

Across the 4 fiscal years on record (2022–2025), the highest was $1.25B in fiscal 2023 and the lowest $744.31M in fiscal 2022.

How is Legend Biotech's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Legend Biotech it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Legend Biotech (LEGN) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/LEGN/net-assets

Underlying data: Yahoo Finance.